Tag results:

Industry & Policy News

Dr. Prabhu Arumugam Earns $1.8 Million NIH Grant for Innovative Neuroscience Research

[Louisiana Tech University] Dr. Prabhu Arumugam has earned nearly $1.8 million from the US National Institute of Neurological Disorders and Stroke/National Institutes of Health (NIH) Small Business Technology Transfer program to continue his innovative development of implantable biosensor neural probes.

USask Researchers Break Ground with Promising Cancer Treatment

[SaskToday] Dr. James Benson and Dr. Laura Hopkins believe the University of Saskatchewan has the tools to provide groundbreaking cancer treatment services to women across Canada.

UC San Diego Cancer Biologist Receives Claugus Award for Medical Research

[UC San Diego] University of California San Diego cancer biologist Tatiana Hurtado de Mendoza has been named the recipient of the 2023 Claugus Award for Medical Research. The award was established in 2021 by the Foundation For A Better World.

Tulane Professor Elected to National Academy of Medicine for His Global Impact in Cardiovascular Disease Research

[Tulane University] Tulane epidemiologist and professor Dr. Jiang He has been elected to the National Academy of Medicine — one of the highest honors in the fields of health and medicine — for leading hypertension research that has helped transform cardiovascular disease prevention efforts across the globe.

Nipah Virus Is Deadly — But Smart Policy Changes Can Help Quell Pandemic Risk

[Nature] Nipah, a deadly RNA virus that can spill over from bats to humans, has infected six people and killed two in the Indian state of Kerala since August. The virus can cause encephalitis — inflammation of the brain — which manifests as fever, headaches, vomiting and respiratory distress. It has a fatality rate of 40–75%, depending on the strain.

Second Malaria Vaccine to Win Global Approval Is Cheaper and Easier to Make

[Nature] The World Health Organization has endorsed a second malaria vaccine to protect children against the deadly disease, which killed 619,000 people in 2021. Researchers say that the vaccine, known as R21, is easier to make than the first-approved malaria vaccine, called RTS,S, and will be cheaper per dose.

Popular